tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market
BBIO
BridgeBio Pharma
RESEARCH TOOLSreports

BridgeBio Pharma (BBIO) Stock News & Sentiment

Compare
1,453 Followers
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
Premium
Ratings
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
4d ago
BBIO
BridgeBio Pharma: Advancing Late-Stage Pipeline and Near-Term Catalysts Underpin Reaffirmed Buy and $100 Target
Premium
Ratings
BridgeBio Pharma: Advancing Late-Stage Pipeline and Near-Term Catalysts Underpin Reaffirmed Buy and $100 Target
12d ago
BBIO
BridgeBio Pharma Earnings Call Signals Profitable Pivot
Premium
Company Announcements
BridgeBio Pharma Earnings Call Signals Profitable Pivot
23d ago
BBIO
BridgeBio Pharma: Clear Path to 2027 Profitability with Underappreciated Pipeline Upside
Premium
Ratings
BridgeBio Pharma: Clear Path to 2027 Profitability with Underappreciated Pipeline Upside
24d ago
BBIO
BridgeBio: Robust Attruby Launch and Late-Stage Pipeline Support Buy Rating and Path to Sustainable Cash Generation
Premium
Ratings
BridgeBio: Robust Attruby Launch and Late-Stage Pipeline Support Buy Rating and Path to Sustainable Cash Generation
24d ago
BBIO
Bridgebio Pharma (BBIO) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Bridgebio Pharma (BBIO) Q4 Earnings Cheat Sheet
1M ago
BBIO
BridgeBio (BBIO): Buy Rating Supported by Strong Phase 3 Infigratinib Data in Achondroplasia and Growing Commercial Momentum
Premium
Ratings
BridgeBio (BBIO): Buy Rating Supported by Strong Phase 3 Infigratinib Data in Achondroplasia and Growing Commercial Momentum
1M ago
BBIO
More BBIO News >

BBIO News on the Web

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?
Zacks
Bullish
BridgeBio price target raised to $106 from $91 at Mizuho
TipRanks News
Bullish
Bank of America Securities Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)
TipRanks News
Bullish
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Aveanna Healthcare Holdings (AVAH)
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: BridgeBio Pharma (BBIO), Tenet Healthcare (THC)
TipRanks News
Bullish
BridgeBio Pharma Inc at Barclays Global Healthcare Conference Transcript
GuruFocus News
Neutral
BridgeBio presents Phase 3 FORTIFY interim analysis results
TipRanks News
Bullish

News Score - Last 7 Days

Positive
BBIO
Sector Average
Media Buzz
This Week4 articles
Weekly Average9.5 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BBIO’s Media Buzz Sentiment?
4 articles about BBIO were published this week. In an average week, 9.5 articles are published.
    What is BBIO’s weekly average amount of articles?
    In an average week, 9.5 articles about BBIO are published.
      What is BBIO’s News Sentiment?
      100% of articles about BBIO were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        ABOSAcumen Pharmaceuticals
        KMTSKestra Medical Technologies Ltd.
        KHTRFKnight Therapeutics
        OVIDOvid Therapeutics
        ANVSAnnovis Bio
        Showing the stocks with the most bullish news sentiment over the past week